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Nanotechnology involves the study of nature at a very small scale, searching new properties
and  applications. The development of this area of knowledge affects greatly both biotechnol-
ogy  and medicine disciplines. The use of materials at the nanoscale, in particular magnetic
nanoparticles, is currently a prominent topic in healthcare and life science. Due to their
size-tunable physical and chemical properties, magnetic nanoparticles have demonstrated
a  wide range of applications ranging from medical diagnosis to treatment. Combining a
high  saturation magnetization with a properly functionalized surface, magnetic nanoparti-
cles  are provided with enhanced functionality that allows them to selectively attach to target
cells  or tissues and play their therapeutic role in them. In particular, iron oxide nanoparti-
cles  are being actively investigated to achieve highly efﬁcient carcinogenic cell destruction
through magnetic hyperthermia treatments. Hyperthermia in different approaches has been
used  combined with radiotherapy during the last decades, however, serious harmful sec-
ondary effects have been found in healthy tissues to be associated with these treatments.
In  this framework, nanotechnology provides a novel and original solution with magnetic
hyperthermia, which is based on the use of magnetic nanoparticles to remotely induce local
heat  when a radiofrequency magnetic ﬁeld is applied, provoking a temperature increase in
those tissues and organs where the tumoral cells are present. Therefore, one important fac-
tor that determines the efﬁciency of this technique is the ability of magnetic nanoparticlesto  be driven and accumulated in the desired area inside the body. With this aim, magnetic
nanoparticles must be strategically surface functionalized to selectively target the injured
cells and tissues.
© 2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All
new products, devices and techniques. Nanotechnology will.  Backgroundhereas Nanosciences involve the study and comprehen-
ion of nature at a very small scale, nanotechnology means
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become one of the leading ﬁelds of research and development
in the present century, affecting practically all industries and
economic sectors. It will involve disciplines like engineering,
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
d rad398  reports of practical oncology an
physics, chemistry, biology and medicine and its impact will
be guaranteed in virtually all social and economic ﬁelds from
healthcare to food, as well as in others, such as electronics,
telecommunications, transportation, construction, textile or
energy.
Speciﬁcally, healthcare and life science applications are
becoming the most challenging and growing area for nano-
technology based systems and solutions. Nanostructured
drugs and delivery systems targeted to speciﬁc sites in the
body, biocompatible nanomaterials for replacement of dam-
aged body parts, innovative bone and tissue reengineering
technologies and reliable and cost effective lab-on-a-chip
biosensors for cancer diagnosis are just a few examples
of high value added by nanotechnology for applications in
medicine.1–3
Nanoparticles are perhaps the most prominent nanoma-
terial in healthcare and life sciences. When particle size
is reduced to the nanoscale (1–100 nm)  materials exhibit
remarkably unique size-dependent physical, chemical and
biological properties. From the practical side of nanoparti-
cles applied to medicine, the control and implementation of
magnetic properties are among the most practical applica-
tions of nanoparticles for cancer diagnosis and treatment. Its
research involves the design, synthesis and characterization
of a wide variety of unconventional magnetic nanoparti-
cles and core-shell nanostructures. Depending on particle
size, composition, structure and physico-chemical properties,
magnetic nanoparticles have demonstrated a diverse range of
useful applications from magnetic resonance imaging, hyper-
thermia, separation or drug-delivery to catalysis.4–6
Radiation therapy or radiotherapy is based on the use of
ionizing radiation to control or kill tumoral tissue. Tumor
cells show an increased metabolism, higher rates of glycolysis
and enhanced radiosensitivity as compared to normal cells,
making them more  vulnerable to radiation. The efﬁciency of
radiotherapy relies on the irreversible damage that the ion-
izing radiation provokes to the DNA of injured cells, which
eventually kills them or avoids their reproductive cycle, con-
trolling in this way the progress of the tumor.
During the treatment of tumoral tissues with radiothe-
rapy special care must be taken to avoid radiation exposure
of surrounding healthy tissues in order to provide the patient
with an improved quality life in the medium and long term
future. In fact, one of the main aims of the new radio-
therapy techniques has been to reduce the radiation dose
affecting adjacent healthy organs or tissues while keeping
the therapeutic dose to the tumoral ones.7 In recent years,
new techniques of treatment using radiotherapy (IGRT, VMAT,
etc.)8,9 have paid special attention on this issue, allowing a
much better tumor control with reduced harmful side effects
caused by high doses on healthy tissues adjacent to the treated
tumor regions. It is important to remark that this reduction in
the radiation dose affecting adjacent tissues or organs must
never lead to underdose in the tumor areas, as this could even-
tually lead to local recurrence in the medium-term future.
As discussed above, radiotherapy treatment is performed
at tissue or organ size scales, not at cellular level, so it is
important to delimit as precisely as possible the volume of
the injured region to be irradiated. This area delimitation
also includes certain normal tissue that could be somehowiotherapy 1 8 ( 2 0 1 3 ) 397–400
affected by tumor cells and which is recommended to be
removed in order to achieve a better control of the tumor.
This issue is traditionally based on both clinical evidence and
biochemical analysis of the tissue. Therefore, it is today a chal-
lenge to kill and control tumors at cellular level, for example
using targets or markers able to identify and selectively attach
to tumor cells, allowing a more  localized treatment and erad-
ication of the malign cells whereas the harmful secondary
effects induced on the healthy ones would be signiﬁcantly
reduced.
Nowadays, the design of multifunctional nanoparticles are
able to fulﬁll several requirements for a speciﬁc application
is the basis of multidisciplinary approaches to the prob-
lem. In the case of biomedical applications, one of the main
goals is to synthesize multifunctional magnetic nanoparticles
that exhibit the highest saturation magnetization as pos-
sible and have surfaces properly functionalized that allow
them to selectively attach to target cells or tissues.10 DNA
probes, antibodies and other chemical structures are com-
monly used to achieve this high demanded selectivity.11 For
a wide range of applications, the use of colloidal iron oxide
and iron oxide-based core-shell nanostructures have attracted
much attention.12 Although other materials can be found
that fulﬁll more  appropriately the magnetic requirements for
biomedical applications (i.e. materials with higher saturation
magnetization), other concepts such as biocompatibility or
toxicity must be taken into account. Iron oxides not only show
interesting size-dependent magnetic properties and can be
functionalized with both organic and inorganic compounds,
but also they are thought to be biocompatible and non-toxic,
which makes them excellent candidates for biomedical appli-
cations and in in-vivo experiments.13
2.  MNP-based  hyperthermia  as  anti-cancer
therapy
Iron oxide based nanoparticles with superior magnetic proper-
ties and properly surface functionalized are being intensively
investigated to achieve highly efﬁcient carcinogenic cell
destruction through hyperthermia treatments. In particular,
it is difﬁcult to ﬁnd a deﬁnition for hyperthermia not linked
to cancer therapy. Most deﬁnitions available of hyperthermia
therapy come from health organizations or institutions. Here,
we would like to cite one from the National Cancer Institute
from United States of America, in which therapeutic hyper-
thermia is deﬁned as: A type of treatment in which body tissue
is exposed to high temperatures to damage and kill cancer cells or
to make cancer cells more sensitive to the effects of radiation and
certain anticancer drugs. This deﬁnition is not new. In fact, dif-
ferent approaches have been used to apply hyperthermia in
tumor regions,14 but with harmful secondary effects in the
healthy tissues. This is the case of many  techniques involv-
ing laser, ionizing radiation and microwaves14 as tools to heat
up malignant body tissues. Although these techniques are
able to increase the intracellular temperature up to the cellu-
lar death, additionally they can provoke harmful side effects
such as ionization of the genetic material or lack of selective-
ness in radiation and microwaves therapies, respectively, that
affect the surrounding healthy tissues. This encouraged the
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earch of new mechanisms capable of increasing the tem-
erature of damaged areas while keeping the rest of tissues
ealthy. Nanotechnology has just provided a novel and origi-
al solution to this problem with the magnetic hyperthermia.
agnetic hyperthermia allows to remotely induce local heat
y means of the magnetic energy losses of magnetic nanopar-
icles under an oscillating magnetic ﬁeld. In other words, the
bility of some magnetic nanoparticles to transform the elec-
romagnetic energy into heat allows the temperature increase
n well- deﬁned regions in the human body where the tumor
ells and the nanoparticles are located. Therefore, the activa-
ion of these nanoparticles as nanoheaters can be controlled
xternally by applying or removing an oscillating magnetic
eld. The electromagnetic radiation used in magnetic hyper-
hermia is in the range of the radio-frequency (between several
Hz and 1 MHz). This radiation is completely healthy and
hows enough penetration depth to access inner organs or tis-
ues in the body. The speciﬁcity of this technique is achieved
y the higher sensitivity of the tumoral cells to temperature
ncreases above 42◦C, temperatures at which the natural enzy-
atic processes that keep the cells alive are destroyed, so that
llowing their selective killing.15 However, the apparent sim-
licity of the technique demands the fulﬁllment of several
equirements to get the desired therapy effect. For biomedical
pplications, magnetic nanoparticles are preferred to show a
uperparamagnetic behavior,16 meaning that the magnetiza-
ion drops to zero when the applied magnetic ﬁeld is removed.
his fact implies that no coercive forces or remanence exist,
reventing magnetic dipolar interactions between particles
nd, eventually, their aggregation, which could lead to seri-
us adverse problems derived from the formation of clots
n the blood circulation system. As previously indicated, the
aturation magnetization should be also as high as possible
n order to guarantee the efﬁcient heating of the nanopar-
icles under the oscillating magnetic ﬁeld. And this fact is
ery closely related to the particle size and distribution of the
anoparticles. The superparamagnetic properties of magnetic
anoparticles are size-dependent. An increase in the parti-
le size will lead to higher saturation magnetization values
nd better performance for magnetic hyperthermia applica-
ions. However, this is true when the particle size is below a
ritical size above which magnetic nanoparticles become fer-
omagnetic (superparamagnetic limit), which is in principle an
ndesired magnetic behavior for biomedical applications due
o a potential particle aggregation phenomena. On the other
and, the particle size is an issue of crucial interest in many
iomedical applications in which the use of very small parti-
les is highly desired to act as heat nano-sources in tumoral
egions of limited size access. The commonest barrier found
n most tissues is the continuous blood capillaries type, so the
eparation between the endothelial cells along the basement
embrane will determine the efﬁciency of the hyperther-
ia  therapy. A suitable balance should be found between the
anoparticles size distribution and their magnetic properties,
ecause too small nanoparticles could not show hyperther-
ia  effect whereas too big nanoparticles could not be able toross the endothelial barrier through the continuous capillar-
es. In this way, the local heating would affect only the external
umor cells, while the inner ones would only experience a soft
hermal effect, not enough to induce cell death.17 Conversely,therapy 1 8 ( 2 0 1 3 ) 397–400 399
if the magnetic nanoparticles are small enough to cross the
blood barrier, they could penetrate and distribute more homo-
geneously inside the tumor, provoking a heat diffusion that
would kill a bigger number of neighboring tumor cells.
Other important requirement is related to the surface func-
tionalization of the nanoparticles. All the nanoparticles used
in biomedical applications are surface functionalized for sev-
eral reasons: their physico-chemical properties should not
be deteriorated in the medium (showing resistance against
biological pH changes, hydrophobicity or hydrophilicity, etc.),
they should be properly attached to ligands for speciﬁc recog-
nition of the desired species (molecules, cells, tissues, organs)
or to carry drugs that will be administered locally in the area
of interest under certain internal or external stimuli.11,18–20
Therefore, the success of using magnetic nanoparticles in
biomedicine depends greatly on our ability to drive them to
the target of interest.
There are several strategies of surface functionalization
using different coating agents and biomolecules that help
us to achieve this goal. Among them, we can mention poly-
mers, viruses, antibodies (that speciﬁcally recognize proteins),
aptamers (show high afﬁnity to certain molecules), etc. In the
particular case of magnetic nanoparticles, one of the most
desirable administration routes is through intravenous injec-
tion, so the additional creation of sufﬁciently strong magnetic
forces by means of permanent magnets could guide them
to the target tissue, overcoming the blood ﬂow forces natu-
rally generated in the blood circulation system. Additionally
to the preservation of the chemical–physical properties of
the nanoparticles, a suitable particle surface modiﬁcation or
coating is also a useful tool to improve their biocompatibility
and decrease as much as possible their toxicity, slipping past
and avoiding the inmunosystem actuators. For hyperthermia
therapy applications, it is very convenient that nanoparticles
reach their target and stay in place long enough to allow
a continued treatment, if necessary. Several multifunctional
nanostructures are being widely researched for biomedical
applications. Among them, we can emphasize core–shell
nanostructures,21 in which the shell not only can preserve
the chemical and physical properties of the core, but also
provide the nanoparticle with a more  feasible surface to be
further functionalized with organic and inorganic functional
molecules and compounds. Dimers (two linked constituents)
or labeled entities (i.e. virus with nanoparticles attached
around it) are other complex structures usually investigated
for biomedical applications. It is important to remark, that
particle surface modiﬁcation is an important parameter that
should be taken carefully into account when researching the
heating properties of magnetic nanoparticles for biomedical
applications. Among other experimental parameters,22 such
as the frequency and amplitude of the electromagnetic oscil-
lating ﬁeld, size-dependent magnetic properties or solvent
viscosity, the coating agent plays a key role for the speciﬁc
absorption rate of nanoparticles for hyperthermia applica-
tions. Again, particle functionalization plays a crucial role in
the hyperthermia performance, since an adequate nanopar-
ticle surface modiﬁcation improves largely their speciﬁcity
and so, the higher the targeting speciﬁcity, the more  selective
killing of target cancer cells will be achieved. In hyperthermia
related cancer therapy applications, the research is mainly
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focused on the design of more  efﬁcient nanoheaters. Also the
hyperthermia response should be as high as possible, since
high speciﬁc absorption rates imply lower time of residence of
the nanoparticles in the human body and also lower dosages
to be administered to the patient.
The killing of tumoral cells through the heat irradiated
from the magnetic nanoparticles attached to them is a direct
consequence of the heating properties of those magnetic
nanoparticles under an applied alternating magnetic ﬁeld.
However, magnetic hyperthermia could allow other syner-
gic actions in addition to the direct killing of the cancer
cells. One example is the magnetically induced drug delivery.
The design of intelligent drug delivery systems is a chal-
lenge in biomedicine due to its potential ability to provide
an additional therapeutic treatment in the damaged area by
controlled release of therapeutic agents. For example, one
strategy to achieve this is to incorporate magnetic nanopar-
ticles into thermoactive polymers or hydrogels, which can
reversibly shrink and expand as a consequence of the temper-
ature increase induced magnetically by hyperthermia effect,
in such a way that they can deliver the loaded therapeutic
drugs in a controlled way.23
To conclude, it just needs to be mentioned that the
synthesis and characterization of these multifunctional
nanoparticles involves the use of highly advanced electron
microscopy techniques, such as high resolution transmission
electron microscopy (HRTEM), scanning electron microscopy
(SEM), atomic force microscopy (AFM), as well as other cut-
ting edge technologies, i.e. X-ray spectroscopy (XPS), X-ray
diffraction (XRD) or vibrant sample magnetometers (VSM and
SQUID-VSM). Comprehensive characterization guarantees
nanoparticle size control, effectiveness of functionalization
strategies and the achievement of the desired physico-
chemical properties.
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